KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Equity (2016 - 2025)

Historic Return on Equity for West Pharmaceutical Services (WST) over the last 16 years, with Q4 2025 value amounting to 0.15%.

  • West Pharmaceutical Services' Return on Equity fell 200.0% to 0.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.15%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.16% for FY2025, which is 100.0% down from last year.
  • West Pharmaceutical Services' Return on Equity amounted to 0.15% in Q4 2025, which was down 200.0% from 0.16% recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Return on Equity ranged from a high of 0.28% in Q1 2022 and a low of 0.15% during Q4 2025
  • Its 5-year average for Return on Equity is 0.21%, with a median of 0.2% in 2023.
  • In the last 5 years, West Pharmaceutical Services' Return on Equity skyrocketed by 1000bps in 2021 and then plummeted by -1000bps in 2023.
  • West Pharmaceutical Services' Return on Equity (Quarter) stood at 0.28% in 2021, then decreased by -22bps to 0.22% in 2022, then fell by -9bps to 0.2% in 2023, then dropped by -12bps to 0.18% in 2024, then fell by -12bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q4 2025, 0.16% for Q3 2025, and 0.17% during Q2 2025.